POP Medical developed and received FDA clearance in 2016 for a minimally-invasive, meshless, dissectionless solution for the repair of uterine prolapse. The POP approach is an easier and shorter procedure with fewer complications than current treatments. POP is seeking funding to conduct a Post-Marketing Study, build a commercial organization prior to a full-scale launch and complete regulatory clearance in the EU.